![](/img/cover-not-exists.png)
Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations
Tamiya, Akihiro, Tamiya, Motohiro, Shiroyama, Takayuki, Saijo, Nobuhiko, Nakatani, Takeshi, Minomo, Shojiro, Tsuji, Taisuke, Takeuchi, Naoko, Omachi, Naoki, Kurata, Kanako, Suzuki, Hidekazu., Okamoto,Volume:
32
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-014-0474-x
Date:
March, 2015
File:
PDF, 312 KB
english, 2015